Development of an Anti-microRNA Therapy for the Treatment of Myotonic Dystrophy Type 1 - The ArthemiR Clinical Trial
Tides 2027 · 29 April 2027 · 14:00–14:30
Development of an Anti-microRNA Therapy for the Treatment of Myotonic Dystrophy Type 1 - The ArthemiR Clinical Trial was a session at Tides 2027 on 29 April 2027 in Boston.